2 Worrying Points Investors Missed in Netflix Inc.’s Blowout Quarter
It wasn't all good news in the streaming video giant's second-quarter report last week.
The Zacks Analyst Blog Highlights: Google, Netflix, Anacor Pharmaceuticals, Synergy Pharmaceuticals,
The Zacks Analyst Blog Highlights: Google, Netflix, Anacor Pharmaceuticals, Synergy Pharmaceuticals, Advanced Energy Industries, TTM Technologies and TransAct Technologies - Press Releases
Why Netflix Inc.'s Subscriber Growth Will Keep Accelerating
The Internet TV leader keeps dazzling subscribers and investors alike. Here's why its dramatic growth won't end anytime soon.
2 Reasons Investors Love Netflix, Inc. Stock
Wondering why Netflix stock is soaring? Here are a few of the key reasons.